fluchloralin has been researched along with Diabetes Mellitus, Type 2 in 2 studies
*Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, B; Jing, T; Li, H; Ma, J; Su, X; Wang, H; Zhai, X; Zhou, Y | 1 |
| Jing, T; Lee, KO; Li, FF; Li, HQ; Liu, BL; Lu, CF; Ma, JH; Su, XF; Sun, R; Wang, J; Xu, XH; Ye, L; Yin, GP | 1 |
1 trial(s) available for fluchloralin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Evaluating Glycemic Control During Basalin or Lantus Administration in Adults With Controlled Type 2 Diabetes Mellitus Using Continuous Glucose Monitoring.
Topics: Aged; Aniline Compounds; Diabetes Mellitus, Type 2; Female; Glycemic Control; Humans; Hypoglycemic Agents; Insulin Glargine; Male; Middle Aged; Prospective Studies | 2021 |
1 other study(ies) available for fluchloralin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
A comparison of clinical efficacy and economic value in Basalin- and Lantus-treated patients with type 2 diabetes using continuous glucose monitoring system.
Topics: Adolescent; Adult; Aniline Compounds; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Insulin Glargine; Male; Middle Aged; Monitoring, Physiologic; Treatment Outcome; Young Adult | 2018 |